SOLAR-PROMOTION-GMBH
29.5.2024 14:04:30 CEST | Business Wire | Press release
The German government’s goal is to have an equal share of large-scale power plants and roof-mounted systems. In 2023, the large-scale ground-mounted segment was able to increase by 45 percent. With the adoption of Solar Package I, this segment will continue to grow. The package of measures aims to reduce the red tape associated with solar deployment in order to achieve an annual growth of 22 gigawatt peak from 2026. The latest applications, products and business models for large-scale PV power plants will be on display at Intersolar Europe, the world’s leading exhibition for the solar industry. It will be held in Munich from June 19–21 as part of The smarter E Europe, the continent’s largest alliance of exhibitions for the energy industry. Some 3,000 exhibitors and over 115,000 visitors from all corners of the globe are expected to attend. The event will take place across 19 exhibition halls and an Outdoor Area.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240529516051/en/
Intersolar Europe presents innovations in the field of hybrid systems. (© Solar Promotion GmbH)
Hybrid power plants consisting of PV and wind power or storage, or both, offer various benefits: Sun and wind complement each other’s generation profiles and can be combined in a system, making optimal use of energy infrastructure such as interconnection points and the space required to implement the system. The combination with energy storage comes with additional advantages: It can smooth out the volatility of renewables, and the stored electricity can be fed into the grid when it is needed – or it can be traded for a profit. Energy arbitrage enables the targeted provision and marketing of solar and wind energy on the energy exchange. The electricity is stored when the price is low or a lot of renewable electricity is being produced. When it is profitable to sell the stored electricity, it is fed into the grid.
The latest technologies in operation and maintenance
Artificial intelligence (AI) is all the rage right now. It is also increasingly being used in the solar industry, especially in operations and maintenance (O&M). The AI-driven detection and analysis of incidents and deviations in operations and the standardized creation and selection of tickets are processes in which AI can be used to quickly process large amounts of data. In O&M, AI helps free up human resources for more complex tasks and standardize operations. What’s more, AI-supported software solutions can process weather data and create generation forecasts.
Special solar systems: parking lot PV, agricultural PV and floating PV
With Solar Package I, the “special solar systems” defined in the German Renewable Energy Sources Act EEG now have their own tender segment. These applications are becoming more prevalent and dual land use concepts are coming to the forefront of solar deployment plans. The maximum value for tenders has been raised to 9.5 cents/kWh. The products in this segment are rapidly evolving: carport substructures, elevated vertical and horizontal solar technology with and without trackers for agricultural PV, and mounting solutions for floating PV.
Intersolar Europe
As the world’s leading exhibition for the solar industry, Intersolar Europe demonstrates the enormous vitality of the solar market. For more than 30 years, it has been providing a networking opportunity for key players, focusing on the latest trends, developments and business models under the motto “Connecting Solar Business”. Intersolar Europe will take place from June 19–21, 2024 as part of The smarter E Europe at Messe München.
For more information, please visit: www.intersolar.de.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529516051/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
